Acacia Research (NASDAQ:ACTG) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Shares of Acacia Research Corporation (NASDAQ:ACTGGet Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $3.56 and traded as high as $4.11. Acacia Research shares last traded at $4.04, with a volume of 227,794 shares trading hands.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. Wall Street Zen raised shares of Acacia Research from a “hold” rating to a “buy” rating in a report on Saturday, November 15th. Weiss Ratings reissued a “sell (d)” rating on shares of Acacia Research in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

Check Out Our Latest Stock Report on ACTG

Acacia Research Stock Up 1.5%

The company has a quick ratio of 8.11, a current ratio of 8.63 and a debt-to-equity ratio of 0.16. The firm’s 50-day moving average price is $3.81 and its 200 day moving average price is $3.56. The firm has a market cap of $389.70 million, a P/E ratio of 80.82 and a beta of 0.57.

Acacia Research (NASDAQ:ACTGGet Free Report) last posted its earnings results on Wednesday, November 5th. The business services provider reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.13. Acacia Research had a net margin of 1.70% and a return on equity of 2.45%. The firm had revenue of $59.45 million during the quarter, compared to analyst estimates of $38.00 million.

Institutional Trading of Acacia Research

Large investors have recently added to or reduced their stakes in the business. Citizens Financial Group Inc. RI bought a new stake in Acacia Research during the 4th quarter valued at $187,000. Levin Capital Strategies L.P. increased its holdings in shares of Acacia Research by 10.5% during the fourth quarter. Levin Capital Strategies L.P. now owns 983,261 shares of the business services provider’s stock valued at $3,677,000 after purchasing an additional 93,714 shares during the period. Pekin Hardy Strauss Inc. bought a new stake in shares of Acacia Research during the fourth quarter valued at about $37,000. Peapod Lane Capital LLC raised its stake in shares of Acacia Research by 16.5% during the fourth quarter. Peapod Lane Capital LLC now owns 845,954 shares of the business services provider’s stock valued at $3,216,000 after purchasing an additional 119,783 shares in the last quarter. Finally, Krilogy Financial LLC lifted its holdings in Acacia Research by 3.8% in the fourth quarter. Krilogy Financial LLC now owns 1,243,413 shares of the business services provider’s stock worth $4,899,000 after purchasing an additional 45,015 shares during the period. 86.69% of the stock is currently owned by institutional investors and hedge funds.

Acacia Research Company Profile

(Get Free Report)

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.

Recommended Stories

Receive News & Ratings for Acacia Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acacia Research and related companies with MarketBeat.com's FREE daily email newsletter.